Regulus Promotes Mark Deeg, M.D. PhD to Chief Medical Officer

LA JOLLA, Calif., June 13, 2017 -- (Healthcare Sales & Marketing Network) -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced the promo... Biopharmaceuticals, Personnel Regulus Therapeutics, microRNA

Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news